Impact on the Nutritional State and the Quality of Life
Recruitment status was Recruiting
The prevalence of malnutrition in cancerous patients varies between 50% and 80%. It is variable in function: the location and the extension of the tumor, of the general state , of age, of the socio-economic class and the pain. The health consequences of a malnutrition are very important: aggravation of the state of health, complications of treatment, hospitalization, alteration of the quality of life and decrease the survival, and the treatment response.
Nutrition being very important in patients, there are recommendations for the nutritional care of these patients, formulated by the European Society for Clinical Nutrition and Metabolism. The investigators do not know to what extent these recommendations are respected in practice and their influence on the nutritional status and the quality of life of patients.
The investigators therefore propose to assess the conformity of the nutritional care patients in clinical practice in relation to the European recommendations and in a second time to assess the influence of this compliance or non-compliance on the nutritional status clinical and biological of cancerous patients under chemotherapy, on their quality of life, on their response to treatment and on their survival.
The investigators will try to identify factors that may be linked to the non-compliance such as the characteristics of the cancer disease, socio-demographic characteristics of the subject and the factors related to the structure in which it is supported.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Conformity With European Recommendations Concerning the Nutritional Care of the Cancerous Patients Benefiting From a Treatment by Chemotherapy Impact on the Nutritional State and the Quality of Life|
- quality of life's improvement [ Time Frame: 3 YEARS ] [ Designated as safety issue: No ]
- improvement of treatment effectiveness, [ Time Frame: 3 YEARS ] [ Designated as safety issue: No ]
- improvement of their survival [ Time Frame: 3 YEARS ] [ Designated as safety issue: No ]
- improvement of the screening of the undernutrition [ Time Frame: 3 YEARS ] [ Designated as safety issue: No ]
- the answer to the treatment [ Time Frame: 3 years ] [ Designated as safety issue: No ]
- the estimation of the survival with regard to the nutritional state of the patient. [ Time Frame: 3 years ] [ Designated as safety issue: No ]
|Study Start Date:||September 2011|
|Estimated Study Completion Date:||February 2015|
|Estimated Primary Completion Date:||September 2014 (Final data collection date for primary outcome measure)|
the patients benefiting from treatment by chemotherapy.
|Other: answering questionnare in differents time of the treatment|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01687335
|Contact: sandrine email@example.com|
|Assistance Publique Hopitaux de Marseille||Active, not recruiting|
|Marseille, France, 13354|
|Assistance Publique Hopitaux de Marseille||Recruiting|
|Marseille, France, 13354|
|Contact: SANDRINE OLIVET firstname.lastname@example.org|
|Study Director:||BERNARD BELAIGUES||Assistance Publique hôpitaux de Marseille|